Therapeutic success in Paget disease.
D000284:Administration, Oral; D000469:Alkaline Phosphatase / Q000097:blood; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002116:Calcitonin / Q000008:administration & dosage / Q000627:therapeutic use; D012968:Etidronic Acid / Q000627:therapeutic use; D006801:Humans; D006909:Hydroxyproline / Q000097:blood / Q000652:urine; D007273:Injections, Intramuscular; D007279:Injections, Subcutaneous; D009943:Organophosphorus Compounds / Q000627:therapeutic use; D010001:Osteitis Deformans / Q000188:drug therapy*; D010010:Osteoclasts / Q000187:drug effects
D000970:Antineoplastic Agents; D009943:Organophosphorus Compounds; D002116:Calcitonin; D000469:Alkaline Phosphatase; D012968:Etidronic Acid; D006909:Hydroxyproline